Keivan Gohari Moghadam

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost et al. · JAMA · 2021 · 653 citations · Full text

Pharmacy, Pharmacotherapy, Critical Care Pharmacology +16

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 79 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Chronic Kidney Disease After Hematopoietic Cell Transplantation: Frequency, Risk Factors, and Outcomes

Fereshteh Saddadi, Monir Sadat Hakemi, Iraj Najafi et al. · Transplantation Proceedings · 2009 · 18 citations

Medicine, Hematology, Nephrology +16

Genotyping of clinical and environmental <i>Aspergillus flavus</i> isolates from Iran using microsatellites

Sadegh Khodavaisy, Hamid Badali, Sassan Rezaie et al. · Mycoses · 2016 · 18 citations

Life Sciences, Genetics, Microbiology +16

Assessments of pulmonary involvement in patients with systemic sclerosis.

Keivan Gohari Moghadam, Farhad Gharibdoost, Gilda Parastandechehr et al. · PubMed · 2011 · 15 citations

Medicine, Clinical Sciences, Internal Medicine +17